Literature DB >> 8989153

The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures.

A E Abdelmeguid1, E J Topol.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989153     DOI: 10.1161/01.cir.94.12.3369

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  12 in total

Review 1.  Spontaneous and iatrogenic microembolization. A new concept for the pathogenesis of coronary artery disease.

Authors:  R Erbel; G Heusch
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

2.  Patients with coronary stenosis and a fractional flow reserve of ≥0.75 measured in daily practice at the VU University Medical Center.

Authors:  N Oud; K M Marques; J G F Bronzwaer; S Brinckman; C P Allaart; C C de Cock; Y Appelman
Journal:  Neth Heart J       Date:  2010-09       Impact factor: 2.380

3.  Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk.

Authors:  D P Chew; D L Bhatt; A M Lincoff; K Wolski; E J Topol
Journal:  Heart       Date:  2005-12-30       Impact factor: 5.994

Review 4.  Chest pain after coronary interventional procedures. Incidence and pathophysiology.

Authors:  A Jeremias; S Kutscher; M Haude; D Heinen; D Baumgart; J Herrmann; R Erbel
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

Review 5.  Coronary microembolization--its role in acute coronary syndromes and interventions.

Authors:  R Erbel; G Heusch
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

6.  Prevalence of microvascular disease in patients with significant coronary artery disease.

Authors:  J Qian; J Ge; D Baumgart; S Sack; M Haude; R Erbel
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

7.  Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.

Authors:  Oyku Gulmez; Aylin Yildirir; Gamze Kaynar; Didem Konas; Alp Aydinalp; Cagatay Ertan; Bulent Ozin; Haldun Muderrisoglu
Journal:  J Thromb Thrombolysis       Date:  2007-06-16       Impact factor: 2.300

Review 8.  Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide.

Authors:  Ian C Gilchrist
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 9.  The impact of surgical and percutaneous coronary revascularization on the cardiac myocyte.

Authors:  Kamal R Khabbaz; Sidney Levitsky
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

10.  Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials.

Authors:  Christoph B Olivier; Vandana Sundaram; Deepak L Bhatt; Sergio Leonardi; Renato D Lopes; Victoria Y Ding; Lingyao Yang; Gregg W Stone; Ph Gabriel Steg; C Michael Gibson; Christian W Hamm; Matthew J Price; Harvey D White; Manisha Desai; Donald R Lynch; Robert A Harrington; Kenneth W Mahaffey
Journal:  Int J Cardiol       Date:  2018-06-08       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.